BIOMAT Database Logo BIOMAT Database Logo

The human dopamine receptor D2 (DRD2) gene is associated with tardive dyskinesia in patients with schizophrenia. 2006

Ying-Jay Liou, and I-Ching Lai, and Ding-Lieh Liao, and Jen-Yeu Chen, and Chao-Cheng Lin, and Chih-Yuan Lin, and Chun-Ming Chen, and Ya-Mei Bai, and Tzu-Ting Chen, and Ying-Chieh Wang

UI MeSH Term Description Entries
D008297 Male Males
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D004409 Dyskinesia, Drug-Induced Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199) Dyskinesia, Medication-Induced,Medication-Induced Dyskinesia,Drug-Induced Dyskinesia,Drug-Induced Dyskinesias,Dyskinesia, Drug Induced,Dyskinesia, Medication Induced,Dyskinesias, Drug-Induced,Dyskinesias, Medication-Induced,Medication Induced Dyskinesia,Medication-Induced Dyskinesias
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder
D012694 Serine A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids. L-Serine,L Serine
D014150 Antipsychotic Agents Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. Antipsychotic,Antipsychotic Agent,Antipsychotic Drug,Antipsychotic Medication,Major Tranquilizer,Neuroleptic,Neuroleptic Agent,Neuroleptic Drug,Neuroleptics,Tranquilizing Agents, Major,Antipsychotic Drugs,Antipsychotic Effect,Antipsychotic Effects,Antipsychotics,Major Tranquilizers,Neuroleptic Agents,Neuroleptic Drugs,Tranquillizing Agents, Major,Agent, Antipsychotic,Agent, Neuroleptic,Drug, Antipsychotic,Drug, Neuroleptic,Effect, Antipsychotic,Major Tranquilizing Agents,Major Tranquillizing Agents,Medication, Antipsychotic,Tranquilizer, Major
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control
D017448 Receptors, Dopamine D2 A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects. D2-class receptor genes contain INTRONS, and the receptors inhibit ADENYLYL CYCLASES. Dopamine D2 Receptors,Dopamine-D2 Receptor,D2 Receptors, Dopamine,Dopamine D2 Receptor,Receptor, Dopamine-D2

Related Publications

Ying-Jay Liou, and I-Ching Lai, and Ding-Lieh Liao, and Jen-Yeu Chen, and Chao-Cheng Lin, and Chih-Yuan Lin, and Chun-Ming Chen, and Ya-Mei Bai, and Tzu-Ting Chen, and Ying-Chieh Wang
Meta-analysis of two dopamine D2 receptor gene polymorphisms with tardive dyskinesia in schizophrenia patients.
September 2007, Molecular psychiatry,
Ying-Jay Liou, and I-Ching Lai, and Ding-Lieh Liao, and Jen-Yeu Chen, and Chao-Cheng Lin, and Chih-Yuan Lin, and Chun-Ming Chen, and Ya-Mei Bai, and Tzu-Ting Chen, and Ying-Chieh Wang
Dopamine D2 receptor gene (DRD2) is associated with alcoholism with conduct disorder.
February 2001, Alcoholism, clinical and experimental research,
Ying-Jay Liou, and I-Ching Lai, and Ding-Lieh Liao, and Jen-Yeu Chen, and Chao-Cheng Lin, and Chih-Yuan Lin, and Chun-Ming Chen, and Ya-Mei Bai, and Tzu-Ting Chen, and Ying-Chieh Wang
Association of TaqI A polymorphism of dopamine D2 receptor gene and tardive dyskinesia in schizophrenia.
April 1997, Biological psychiatry,
Ying-Jay Liou, and I-Ching Lai, and Ding-Lieh Liao, and Jen-Yeu Chen, and Chao-Cheng Lin, and Chih-Yuan Lin, and Chun-Ming Chen, and Ya-Mei Bai, and Tzu-Ting Chen, and Ying-Chieh Wang
Association between three functional polymorphisms of dopamine D2 receptor gene and tardive dyskinesia in schizophrenia.
December 2001, American journal of medical genetics,
Ying-Jay Liou, and I-Ching Lai, and Ding-Lieh Liao, and Jen-Yeu Chen, and Chao-Cheng Lin, and Chih-Yuan Lin, and Chun-Ming Chen, and Ya-Mei Bai, and Tzu-Ting Chen, and Ying-Chieh Wang
D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele.
December 1997, Pharmacogenetics,
Ying-Jay Liou, and I-Ching Lai, and Ding-Lieh Liao, and Jen-Yeu Chen, and Chao-Cheng Lin, and Chih-Yuan Lin, and Chun-Ming Chen, and Ya-Mei Bai, and Tzu-Ting Chen, and Ying-Chieh Wang
Tardive dyskinesia in relation to estimated dopamine D2 receptor occupancy in patients with schizophrenia: analysis of the CATIE data.
March 2014, Schizophrenia research,
Ying-Jay Liou, and I-Ching Lai, and Ding-Lieh Liao, and Jen-Yeu Chen, and Chao-Cheng Lin, and Chih-Yuan Lin, and Chun-Ming Chen, and Ya-Mei Bai, and Tzu-Ting Chen, and Ying-Chieh Wang
The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction.
January 2014, Annals of human genetics,
Ying-Jay Liou, and I-Ching Lai, and Ding-Lieh Liao, and Jen-Yeu Chen, and Chao-Cheng Lin, and Chih-Yuan Lin, and Chun-Ming Chen, and Ya-Mei Bai, and Tzu-Ting Chen, and Ying-Chieh Wang
Remoxipride, a selective dopamine D2 receptor antagonist, in tardive dyskinesia.
January 1988, Psychopharmacology,
Ying-Jay Liou, and I-Ching Lai, and Ding-Lieh Liao, and Jen-Yeu Chen, and Chao-Cheng Lin, and Chih-Yuan Lin, and Chun-Ming Chen, and Ya-Mei Bai, and Tzu-Ting Chen, and Ying-Chieh Wang
No Evidence for an Association between Dopamine D2 Receptor Polymorphisms and Tardive Dyskinesia in Korean Schizophrenia Patients.
March 2011, Psychiatry investigation,
Ying-Jay Liou, and I-Ching Lai, and Ding-Lieh Liao, and Jen-Yeu Chen, and Chao-Cheng Lin, and Chih-Yuan Lin, and Chun-Ming Chen, and Ya-Mei Bai, and Tzu-Ting Chen, and Ying-Chieh Wang
Dopamine D2 receptor gene (DRD2) haplotypes in Caucasians.
November 1996, Gene,
Copied contents to your clipboard!